Stay updated with breaking news from Nasdaq Krtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Free Report) has received a consensus rating of “Hold” from the sixteen analysts that are presently covering the stock, Marketbeat reports. Ten research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12 month price objective among […]
Karuna Therapeutics (NASDAQ:KRTX – Get Free Report)‘s stock had its “neutral” rating reissued by equities researchers at Mizuho in a report released on Friday, Benzinga reports. They presently have a $330.00 price objective on the stock, up from their previous price objective of $245.00. Mizuho’s target price would indicate a potential upside of 5.08% from […]
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Free Report) has been given a consensus rating of “Hold” by the eighteen ratings firms that are covering the firm, Marketbeat.com reports. Ten analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1-year price target among brokers […]
HC Wainwright lowered shares of Karuna Therapeutics (NASDAQ:KRTX – Free Report) from a buy rating to a neutral rating in a report issued on Tuesday morning, Marketbeat reports. They currently have $330.00 price objective on the stock, up from their prior price objective of $300.00. KRTX has been the topic of several other reports. JMP […]
Morgan Stanley reissued their equal weight rating on shares of Karuna Therapeutics (NASDAQ:KRTX – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. They currently have a $330.00 price objective on the stock, up from their prior price objective of $295.00. KRTX has been the topic of several other reports. […]